BW234 - A NONDOPAMINE RECEPTOR-BLOCKING ANTIPSYCHOTIC DRUG WITHOUT EXTRAPYRAMIDAL SIDE-EFFECTS

被引：20

作者：

DAVIDSON, J

DREN, A

MILLER, R

MANBERG, P

KILTS, C

WINGFIELD, M

机构：

[1] DUKE UNIV,MED CTR,DEPT PSYCHIAT,DURHAM,NC 27710

[2] DUKE UNIV,MED CTR,DEPT MED RES,DURHAM,NC 27710

[3] BURROUGHS WELLCOME CO,RES TRIANGLE PK,NC 27709

[4] MENDOTA MENTAL HLTH CTR,FORENS TRAINING PROGRAM,MADISON,WI

[5] JOHN UMSTEAD HOSP,DEPT NEUROL,CHAPEL HILL,NC

[6] UNIV MADISON,DEPT PSYCHIAT,MADISON,WI

来源：

DRUG DEVELOPMENT RESEARCH | 1985年 / 6卷 / 01期

关键词：

D O I：

10.1002/ddr.430060103

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：13 / 17

页数：5

共 5 条

[1] AN EARLY PHASE-II CLINICAL-TRIAL OF BW234U IN THE TREATMENT OF ACUTE SCHIZOPHRENIA IN NEWLY ADMITTED PATIENTS [J].

CHOUINARD, G ;

ANNABLE, L .

PSYCHOPHARMACOLOGY, 1984, 84 (02) :282-284

[2]

DAVIDSON J, 1982, Psychopharmacology Bulletin, V18, P173

[3] BW234U, (CIS-9-[3-(3,5-DIMETHYL-1-PIPERAZINYL)PROPYL]CARBAZOLE DIHYDROCHLORIDE) - A NOVEL ANTIPSYCHOTIC AGENT [J].

FERRIS, RM ;

HARFENIST, M ;

MCKENZIE, GM ;

COOPER, B ;

SOROKO, FE ;

MAXWELL, RA .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (06) :388-390

[4] PSYCHOTROPIC ACTIONS OF BW-234U IN THE TREATMENT OF INPATIENT SCHIZOPHRENICS - A DOSE-RANGE STUDY [J].

GUY, W ;

MANOV, G ;

WILSON, WH ;

BAN, TA ;

FJETLAND, OK ;

MANBERG, PJ ;

DREN, AT .

DRUG DEVELOPMENT RESEARCH, 1983, 3 (03) :245-252

[5]

GUY W, 1976, DHEW ADM76338 PUBL

← 1 →